Search results
Gateway - Quartz
Quartz· 2 days agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages ...
India's gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs...
Fortune· 16 hours agoSuch is the interest that the anti-obesity medication market could reach $100 billion by 2030, Goldman Sachs Research said. Indians, meanwhile, have simply been watching this from the sidelines ...
Eli Lilly pharma company debuts new Concord digs with Gov. Cooper on hand
WJZY via Yahoo Finance· 6 days agoCONCORD, N.C. (QUEEN CITY NEWS) – North Carolina Governor Roy Cooper is in Concord Friday for the...
Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs
Investor's Business Daily· 2 days agoNovo Nordisk remains in buy range from a cup with handle. As a fourth-stage base, this latest...
Employer coverage for weight-loss drugs rises sharply, survey finds By Reuters
Investing.com· 6 days agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Increasing number of employers covering GLP-1 drugs for weight loss, survey finds
BenefitsPRO· 5 days agoInsurer resistance to covering the drugs is a limiting factor for sales growth for drugmakers,...
Gilead's New Revelation For Its Weight-Loss Contender
Investor's Business Daily· 2 days agoOn Friday, shares of Gilead Sciences (GILD) shot up 2.4% after a poster published ahead of the...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
The Motley Fool· 6 days agoWegovy's market-topping position is precarious. Here are three drugs most likely to dethrone Novo...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
CNBC· 1 day agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
South Africa Runs Out of Insulin Pens as Global Supply Shifts to Weight-Loss Drugs
New York Times· 15 hours agoThe shortage highlights a widening gulf in the standard of care for people with diabetes, most of...